Literature DB >> 16104015

Common binding site for disialyllactose and tri-peptide in C-fragment of tetanus neurotoxin.

Seetharaman Jayaraman1, Subramaniam Eswaramoorthy, Desigan Kumaran, Subramanyam Swaminathan.   

Abstract

Clostridial neurotoxins are comprised of botulinum (BoNT) and tetanus (TeNT), which share significant structural and functional similarity. Crystal structures of the binding domain of TeNT complexed with disialyllactose (DiSia) and a tri-peptide Tyr-Glu-Trp (YEW) have been determined to 2.3 and 2.2 A, respectively. Both DiSia and YEW bind in a shallow cleft region on the surface of the molecule in the beta-trefoil domain, interacting with a set of common residues, Asp1147, Asp1214, Asn1216, and Arg1226. DiSia and YEW binding at the same site in tetanus toxin provides a putative site that could be occupied either by a ganglioside moiety or a peptide. Soaking experiments with a mixture of YEW and DiSia show that YEW competes with DiSia, suggesting that YEW can be used to block ganglioside binding. A comparison with the TeNT binding domain in complex with small molecules, BoNT/A and /B, provides insight into the different modes of ganglioside binding. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16104015     DOI: 10.1002/prot.20595

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  15 in total

1.  The structure of the tetanus toxin reveals pH-mediated domain dynamics.

Authors:  Geoffrey Masuyer; Julian Conrad; Pål Stenmark
Journal:  EMBO Rep       Date:  2017-06-23       Impact factor: 8.807

Review 2.  Unique ganglioside binding by botulinum neurotoxins C and D-SA.

Authors:  Abby R Kroken; Andrew P-A Karalewitz; Zhuji Fu; Michael R Baldwin; Jung-Ja P Kim; Joseph T Barbieri
Journal:  FEBS J       Date:  2011-05-31       Impact factor: 5.542

3.  Exceptionally potent human monoclonal antibodies are effective for prophylaxis and treatment of tetanus in mice.

Authors:  Marco Pirazzini; Alessandro Grinzato; Davide Corti; Sonia Barbieri; Oneda Leka; Francesca Vallese; Marika Tonellato; Chiara Silacci-Fregni; Luca Piccoli; Eaazhisai Kandiah; Giampietro Schiavo; Giuseppe Zanotti; Antonio Lanzavecchia; Cesare Montecucco
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

4.  Gangliosides as high affinity receptors for tetanus neurotoxin.

Authors:  Chen Chen; Zhuji Fu; Jung-Ja P Kim; Joseph T Barbieri; Michael R Baldwin
Journal:  J Biol Chem       Date:  2009-07-14       Impact factor: 5.157

Review 5.  Gangliosides in cell recognition and membrane protein regulation.

Authors:  Pablo H H Lopez; Ronald L Schnaar
Journal:  Curr Opin Struct Biol       Date:  2009-07-14       Impact factor: 6.809

6.  Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.

Authors:  Zhuji Fu; Chen Chen; Joseph T Barbieri; Jung-Ja P Kim; Michael R Baldwin
Journal:  Biochemistry       Date:  2009-06-23       Impact factor: 3.162

Review 7.  Receptor and substrate interactions of clostridial neurotoxins.

Authors:  Axel T Brunger; Andreas Rummel
Journal:  Toxicon       Date:  2009-03-04       Impact factor: 3.033

8.  Impairment of retrograde neuronal transport in oxaliplatin-induced neuropathy demonstrated by molecular imaging.

Authors:  Dawid Schellingerhout; Lucia G LeRoux; Brian P Hobbs; Sebastian Bredow
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

9.  Interaction between a Novel Oligopeptide Fragment of the Human Neurotrophin Receptor TrkB Ectodomain D5 and the C-Terminal Fragment of Tetanus Neurotoxin.

Authors:  Ana Candalija; Thomas Scior; Hans-Richard Rackwitz; Jordan E Ruiz-Castelan; Ygnacio Martinez-Laguna; José Aguilera
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

Review 10.  Fragment C of tetanus toxin: new insights into its neuronal signaling pathway.

Authors:  Ana C Calvo; Sara Oliván; Raquel Manzano; Pilar Zaragoza; José Aguilera; Rosario Osta
Journal:  Int J Mol Sci       Date:  2012-06-07       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.